Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3692832010 | Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3692834011 | Betamethasone sodium phosphate 1 mg/g and neomycin sulfate 5 mg/g eye ointment | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 46752301000001112 | Neomycin 0.5% / Betamethasone 0.1% eye ointment | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Is a | Betamethasone+neomycin sulfate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Is a | Miscellaneous eye preparations | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has active ingredient | Betamethasone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has active ingredient | Adrenal hormone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Is a | Product containing neomycin in topical dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Is a | Product containing betamethasone in topical dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has active ingredient | Betamethasone sodium phosphate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has active ingredient | Corticosterone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has active ingredient | Neomycin sulfate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has active ingredient | Skin anti-infective | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has active ingredient | Adrenal hormone agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has active ingredient | Bactericide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has active ingredient | Local anti-infective | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Is a | Product containing betamethasone in ophthalmic dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Is a | Product containing neomycin in ophthalmic dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has manufactured dose form | Ocular dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has manufactured dose form | Conventional release eye ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Is a | Product containing betamethasone and neomycin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has concentration strength numerator value | 5 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has concentration strength numerator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has precise active ingredient | Betamethasone sodium phosphate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has precise active ingredient | Neomycin sulfate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has basis of strength substance | Betamethasone sodium phosphate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has basis of strength substance | Neomycin sulfate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Is a | Product containing only betamethasone and neomycin in ocular dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has manufactured dose form | Ocular dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has active ingredient | Neomycin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has manufactured dose form | Conventional release eye ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has active ingredient | Betamethasone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Ophthalmic route | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | ointment.ophthalmic ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Continuous dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Is a | Betamethasone + Neomycin | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has manufactured dose form | Ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Ocular | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has manufactured dose form | Conventional release eye ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has manufactured dose form | Conventional release eye ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has manufactured dose form | Ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has manufactured dose form | Ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has specific active ingredient | Neomycin sulfate | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has specific active ingredient | Betamethasone sodium phosphate | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has dispensed dose form | Ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Has dispensed dose form | Conventional release eye ointment | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Is a | Product containing betamethasone and neomycin | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Betamethasone sodium phosphate+neomycin sulphate 0.1/0.5% eye ointment - product | Is a | False | Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Inferred relationship | Existential restriction modifier | |
| Betnesol-N eye ointment (Celltech Pharmaceuticals Ltd) | Is a | True | Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Inferred relationship | Existential restriction modifier | |
| Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram | Is pack of | False | Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Inferred relationship | Existential restriction modifier | |
| Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram | Has VMP | True | Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR